Literature DB >> 19908045

[Highly differentiated liver tumors: recent developments and their diagnostic application].

P Schirmacher1, T Longerich.   

Abstract

Biopsy diagnosis of early and highly differentiated liver tumors is one of the most challenging tasks in histopathology. During recent years its parameters have changed fundamentally due to shifting clinical algorithms. Modern histopathology has met this challenge by defining new, prognostically relevant subtypes of early hepatocellular carcinoma and by elaborating morphological algorithms and novel immunohistological markers for the differential diagnosis of highly differentiated hepatocellular tumors. In addition, a new, predictive molecular pathological and histological classification of liver cell adenoma has been developed. By means of the consequent application of these new diagnostic tools, together with the so-called 'matrix diagnosis', a reliable diagnosis is achieved in the vast majority of these difficult cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908045     DOI: 10.1007/s00292-009-1214-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  14 in total

1.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Authors:  Luca Di Tommaso; Annarita Destro; Jae Yeon Seok; Emanuela Balladore; Luigi Terracciano; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Ja June Jang; Eunsil Yu; So Young Jin; Emanuela Morenghi; Young Nyun Park; Massimo Roncalli
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

2.  Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.

Authors: 
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

3.  Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.

Authors:  Luca Di Tommaso; Giada Franchi; Young Nyun Park; Barbara Fiamengo; Annarita Destro; Emanuela Morenghi; Marco Montorsi; Guido Torzilli; Maurizio Tommasini; Luigi Terracciano; Luigi Tornillo; Raffaella Vecchione; Massimo Roncalli
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.

Authors:  Kai Breuhahn; Sebastian Vreden; Ramsi Haddad; Susanne Beckebaum; Dirk Stippel; Peer Flemming; Tanja Nussbaum; Wolfgang H Caselmann; Brian B Haab; Peter Schirmacher
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

5.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.

Authors:  Paulette Bioulac-Sage; Sandra Rebouissou; Cristel Thomas; Jean-Frédéric Blanc; Jean Saric; Antonio Sa Cunha; Anne Rullier; Gaëlle Cubel; Gabrielle Couchy; Sandrine Imbeaud; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

6.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Authors:  Yannick Ladeiro; Gabrielle Couchy; Charles Balabaud; Paulette Bioulac-Sage; Laura Pelletier; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

7.  Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.

Authors:  Emmanuelle Jeannot; Karine Poussin; Laurence Chiche; Yannick Bacq; Nathalie Sturm; Jean-Yves Scoazec; Catherine Buffet; Jeanne Tran Van Nhieu; Christine Bellanné-Chantelot; Claudia de Toma; Pierre Laurent-Puig; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

8.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

9.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.

Authors:  Sandra Rebouissou; Mohamed Amessou; Gabrielle Couchy; Karine Poussin; Sandrine Imbeaud; Camilla Pilati; Tina Izard; Charles Balabaud; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  Nature       Date:  2008-11-19       Impact factor: 49.962

10.  Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.

Authors:  Péter Tátrai; Aron Somorácz; Enkhjargal Batmunkh; Peter Schirmacher; András Kiss; Zsuzsa Schaff; Péter Nagy; Ilona Kovalszky
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.